Literature DB >> 26454245

Lipoprotein profiles in human heterozygote carriers of a functional mutation P297S in scavenger receptor class B1.

Stefan A Ljunggren1, Johannes H M Levels2, Kees Hovingh3, Adriaan G Holleboom4, Menno Vergeer5, Letta Argyri6, Christina Gkolfinopoulou7, Angeliki Chroni8, Jeroen A Sierts9, John J Kastelein10, Jan Albert Kuivenhoven11, Mats Lindahl12, Helen Karlsson13.   

Abstract

The scavenger receptor class B type 1 (SR-B1) is an important HDL receptor involved in cholesterol uptake and efflux, but its physiological role in human lipoprotein metabolism is not fully understood. Heterozygous carriers of the SR-B1(P297S) mutation are characterized by increased HDL cholesterol levels, impaired cholesterol efflux from macrophages and attenuated adrenal function. Here, the composition and function of lipoproteins were studied in SR-B1(P297S) heterozygotes.Lipoproteins from six SR-B1(P297S) carriers and six family controls were investigated. HDL and LDL/VLDL were isolated by ultracentrifugation and proteins were separated by two-dimensional gel electrophoresis and identified by mass spectrometry. HDL antioxidant properties, paraoxonase 1 activities, apoA-I methionine oxidations and HDL cholesterol efflux capacity were assessed.Multivariate modeling separated carriers from controls based on lipoprotein composition. Protein analyses showed a significant enrichment of apoE in LDL/VLDL and of apoL-1 in HDL from heterozygotes compared to controls. The relative distribution of plasma apoE was increased in LDL and in lipid-free form. There were no significant differences in paraoxonase 1 activities, HDL antioxidant properties or HDL cholesterol efflux capacity but heterozygotes showed a significant increase of oxidized methionines in apoA-I.The SR-B1(P297S) mutation affects both HDL and LDL/VLDL protein compositions. The increase of apoE in carriers suggests a compensatory mechanism for attenuated SR-B1 mediated cholesterol uptake by HDL. Increased methionine oxidation may affect HDL function by reducing apoA-I binding to its targets. The results illustrate the complexity of lipoprotein metabolism that has to be taken into account in future therapeutic strategies aiming at targeting SR-B1.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ApoE; ApoL-1; HDL; LDL/VLDL; P297S; SR-B1

Mesh:

Substances:

Year:  2015        PMID: 26454245     DOI: 10.1016/j.bbalip.2015.09.006

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  10 in total

Review 1.  The molecular aspects of absorption and metabolism of carotenoids and retinoids in vertebrates.

Authors:  Made Airanthi K Widjaja-Adhi; Marcin Golczak
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2019-11-23       Impact factor: 4.698

Review 2.  SR-B1: A Unique Multifunctional Receptor for Cholesterol Influx and Efflux.

Authors:  Wen-Jun Shen; Salman Azhar; Fredric B Kraemer
Journal:  Annu Rev Physiol       Date:  2017-11-10       Impact factor: 19.318

Review 3.  [Congenital disorders of lipoprotein metabolism].

Authors:  W März; T B Grammer; G Delgado; M E Kleber
Journal:  Herz       Date:  2017-08       Impact factor: 1.443

4.  Hepatic paraoxonase 1 ameliorates dysfunctional high-density lipoprotein and atherosclerosis in scavenger receptor class B type I deficient mice.

Authors:  Xiao-Jie Zhao; Liang-Chen Liu; Cui Guo; Wen-Wen Shen; Jia Cao; Fen Du; Dong-Fang Wu; Hong Yu
Journal:  Ann Transl Med       Date:  2021-07

Review 5.  [Clinical importance of HDL cholesterol].

Authors:  W März; M E Kleber; H Scharnagl; T Speer; S Zewinger; A Ritsch; K G Parhofer; A von Eckardstein; U Landmesser; U Laufs
Journal:  Herz       Date:  2016-11-14       Impact factor: 1.443

Review 6.  HDL cholesterol: reappraisal of its clinical relevance.

Authors:  Winfried März; Marcus E Kleber; Hubert Scharnagl; Timotheus Speer; Stephen Zewinger; Andreas Ritsch; Klaus G Parhofer; Arnold von Eckardstein; Ulf Landmesser; Ulrich Laufs
Journal:  Clin Res Cardiol       Date:  2017-03-24       Impact factor: 5.460

7.  Modified lipoproteins in periodontitis: a link to cardiovascular disease?

Authors:  Stefan Ljunggren; Torbjörn Bengtsson; Helen Karlsson; Carin Starkhammar Johansson; Eleonor Palm; Fariba Nayeri; Bijar Ghafouri; Julia Davies; Gunnel Svensäter; Johanna Lönn
Journal:  Biosci Rep       Date:  2019-03-26       Impact factor: 3.840

8.  Metal additive manufacturing and possible clinical markers for the monitoring of exposure-related health effects.

Authors:  Stefan A Ljunggren; Liam J Ward; Pål Graff; Anders Persson; Malin Leijon Lind; Helen Karlsson
Journal:  PLoS One       Date:  2021-03-18       Impact factor: 3.240

Review 9.  SR-B1, a Key Receptor Involved in the Progression of Cardiovascular Disease: A Perspective from Mice and Human Genetic Studies.

Authors:  Irene Gracia-Rubio; César Martín; Fernando Civeira; Ana Cenarro
Journal:  Biomedicines       Date:  2021-05-27

10.  Lipoprotein modifications by gingipains of Porphyromonas gingivalis.

Authors:  J Lönn; S Ljunggren; K Klarström-Engström; I Demirel; T Bengtsson; H Karlsson
Journal:  J Periodontal Res       Date:  2018-01-17       Impact factor: 4.419

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.